Stock Analysis

Is Nomura Research Institute (TSE:4307) A Risky Investment?

TSE:4307
Source: Shutterstock

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' So it seems the smart money knows that debt - which is usually involved in bankruptcies - is a very important factor, when you assess how risky a company is. We can see that Nomura Research Institute, Ltd. (TSE:4307) does use debt in its business. But the more important question is: how much risk is that debt creating?

Advertisement

When Is Debt Dangerous?

Debt assists a business until the business has trouble paying it off, either with new capital or with free cash flow. In the worst case scenario, a company can go bankrupt if it cannot pay its creditors. However, a more common (but still painful) scenario is that it has to raise new equity capital at a low price, thus permanently diluting shareholders. Having said that, the most common situation is where a company manages its debt reasonably well - and to its own advantage. When we think about a company's use of debt, we first look at cash and debt together.

How Much Debt Does Nomura Research Institute Carry?

You can click the graphic below for the historical numbers, but it shows that Nomura Research Institute had JP¥246.3b of debt in March 2025, down from JP¥267.1b, one year before. However, because it has a cash reserve of JP¥168.6b, its net debt is less, at about JP¥77.7b.

debt-equity-history-analysis
TSE:4307 Debt to Equity History May 30th 2025

How Strong Is Nomura Research Institute's Balance Sheet?

The latest balance sheet data shows that Nomura Research Institute had liabilities of JP¥239.5b due within a year, and liabilities of JP¥251.1b falling due after that. On the other hand, it had cash of JP¥168.6b and JP¥216.7b worth of receivables due within a year. So its liabilities total JP¥105.2b more than the combination of its cash and short-term receivables.

Given Nomura Research Institute has a humongous market capitalization of JP¥3.19t, it's hard to believe these liabilities pose much threat. However, we do think it is worth keeping an eye on its balance sheet strength, as it may change over time.

View our latest analysis for Nomura Research Institute

In order to size up a company's debt relative to its earnings, we calculate its net debt divided by its earnings before interest, tax, depreciation, and amortization (EBITDA) and its earnings before interest and tax (EBIT) divided by its interest expense (its interest cover). The advantage of this approach is that we take into account both the absolute quantum of debt (with net debt to EBITDA) and the actual interest expenses associated with that debt (with its interest cover ratio).

Nomura Research Institute has a low net debt to EBITDA ratio of only 0.42. And its EBIT covers its interest expense a whopping 180 times over. So you could argue it is no more threatened by its debt than an elephant is by a mouse. Also good is that Nomura Research Institute grew its EBIT at 13% over the last year, further increasing its ability to manage debt. The balance sheet is clearly the area to focus on when you are analysing debt. But it is future earnings, more than anything, that will determine Nomura Research Institute's ability to maintain a healthy balance sheet going forward. So if you're focused on the future you can check out this free report showing analyst profit forecasts.

Finally, a company can only pay off debt with cold hard cash, not accounting profits. So the logical step is to look at the proportion of that EBIT that is matched by actual free cash flow. During the last three years, Nomura Research Institute produced sturdy free cash flow equating to 65% of its EBIT, about what we'd expect. This cold hard cash means it can reduce its debt when it wants to.

Portfolio Valuation calculation on simply wall st

Our View

Nomura Research Institute's interest cover suggests it can handle its debt as easily as Cristiano Ronaldo could score a goal against an under 14's goalkeeper. And the good news does not stop there, as its net debt to EBITDA also supports that impression! Zooming out, Nomura Research Institute seems to use debt quite reasonably; and that gets the nod from us. While debt does bring risk, when used wisely it can also bring a higher return on equity. Over time, share prices tend to follow earnings per share, so if you're interested in Nomura Research Institute, you may well want to click here to check an interactive graph of its earnings per share history.

If you're interested in investing in businesses that can grow profits without the burden of debt, then check out this free list of growing businesses that have net cash on the balance sheet.

Valuation is complex, but we're here to simplify it.

Discover if Nomura Research Institute might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About TSE:4307

Nomura Research Institute

Provides consulting, financial information technology (IT) solution, industrial IT solution, and IT platform services in Japan and internationally.

Outstanding track record with excellent balance sheet and pays a dividend.

Advertisement